市場調査レポート
商品コード
1777156

In Vitro毒性試験の世界市場、2025年~2029年

Global In-vitro Toxicity Testing Market 2025-2029


出版日
発行
TechNavio
ページ情報
英文 231 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
In Vitro毒性試験の世界市場、2025年~2029年
出版日: 2025年07月18日
発行: TechNavio
ページ情報: 英文 231 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

In Vitro毒性試験市場は2024-2029年に81億9,240万米ドル、予測期間中のCAGRで11.7%の成長が予測されています。

当レポートでは、In Vitro毒性試験市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、薬剤の失敗を減らすための企業によるIn Vitro毒性試験使用の増加、有害物質の存在、毒物検査に関連する政府のイニシアチブの成長によって牽引されています。

市場範囲
基準年 2025
終了年 2029
予測期間 2025-2029
成長モメンタム 加速
前年比 10.7%
CAGR 11.7%
増分額 81億9,240万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、毒性学の進歩が今後数年間のIn Vitro毒性試験市場の成長を促進する主要な理由の1つであると特定しています。また、化粧品需要の急増や創薬への投資の増加は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024
  • 市場の見通し 2024-2029

第5章 市場規模実績

  • In Vitro毒性試験の世界市場 2019-2023
  • エンドユーザー別セグメント分析 2019-2023
  • タイプ別セグメント分析 2019-2023
  • 技術別セグメント分析 2019-2023
  • 地域別セグメント分析 2019-2023
  • 国別セグメント分析 2019-2023

第6章 定性分析

  • AIの影響:In Vitro毒性試験の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 製薬:市場規模と予測 2024-2029
  • 学術・研究機関:市場規模と予測 2024-2029
  • その他:市場規模と予測 2024-2029
  • 市場機会:エンドユーザー別

第9章 市場セグメンテーション:タイプ別

  • 市場セグメント
  • 比較:タイプ別
  • 細胞毒性試験:市場規模と予測 2024-2029
  • 遺伝毒性試験:市場規模と予測 2024-2029
  • 臓器特異的毒性試験:市場規模と予測 2024-2029
  • 光毒性試験:市場規模と予測 2024-2029
  • 経皮毒性試験:市場規模と予測 2024-2029
  • 市場機会:タイプ別

第10章 市場セグメンテーション:技術別

  • 市場セグメント
  • 比較:技術別
  • 細胞培養技術:市場規模と予測 2024-2029
  • ハイスループットスクリーニング:市場規模と予測 2024-2029
  • OMICS技術:市場規模と予測 2024-2029
  • 計算毒性学:市場規模と予測 2024-2029
  • 市場機会:技術別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2024-2029
  • 欧州:市場規模と予測 2024-2029
  • アジア:市場規模と予測 2024-2029
  • 世界のその他の地域:市場規模と予測 2024-2029
  • 米国:市場規模と予測 2024-2029
  • ドイツ:市場規模と予測 2024-2029
  • 英国:市場規模と予測 2024-2029
  • カナダ:市場規模と予測 2024-2029
  • フランス:市場規模と予測 2024-2029
  • 中国:市場規模と予測 2024-2029
  • 日本:市場規模と予測 2024-2029
  • イタリア:市場規模と予測 2024-2029
  • インド:市場規模と予測 2024-2029
  • ブラジル:市場規模と予測 2024-2029
  • 市場機会:地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Aragen Life Sciences Pvt. Ltd.
  • Bio Rad Laboratories Inc.
  • Catalent Inc.
  • Charles River Laboratories International Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • Gentronix Ltd.
  • Laboratory Corp. of America Holdings
  • Merck KGaA
  • Promega Corp.
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • XENOMETRIX AG

第16章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global In-Vitro Toxicity Testing Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Technology Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits39: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by End-user
  • Exhibits41: Data Table on Comparison by End-user
  • Exhibits42: Chart on Pharmaceutical - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Pharmaceutical - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Pharmaceutical - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Pharmaceutical - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Academic and research institutions - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Academic and research institutions - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits51: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits52: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits53: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits54: Market opportunity by End-user ($ million)
  • Exhibits55: Data Table on Market opportunity by End-user ($ million)
  • Exhibits56: Chart on Type - Market share 2024-2029 (%)
  • Exhibits57: Data Table on Type - Market share 2024-2029 (%)
  • Exhibits58: Chart on Comparison by Type
  • Exhibits59: Data Table on Comparison by Type
  • Exhibits60: Chart on Cytotoxicity testing - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on Cytotoxicity testing - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on Cytotoxicity testing - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on Cytotoxicity testing - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Chart on Genotoxicity testing - Market size and forecast 2024-2029 ($ million)
  • Exhibits65: Data Table on Genotoxicity testing - Market size and forecast 2024-2029 ($ million)
  • Exhibits66: Chart on Genotoxicity testing - Year-over-year growth 2024-2029 (%)
  • Exhibits67: Data Table on Genotoxicity testing - Year-over-year growth 2024-2029 (%)
  • Exhibits68: Chart on Organ-specific toxicity testing - Market size and forecast 2024-2029 ($ million)
  • Exhibits69: Data Table on Organ-specific toxicity testing - Market size and forecast 2024-2029 ($ million)
  • Exhibits70: Chart on Organ-specific toxicity testing - Year-over-year growth 2024-2029 (%)
  • Exhibits71: Data Table on Organ-specific toxicity testing - Year-over-year growth 2024-2029 (%)
  • Exhibits72: Chart on Phototoxicity testing - Market size and forecast 2024-2029 ($ million)
  • Exhibits73: Data Table on Phototoxicity testing - Market size and forecast 2024-2029 ($ million)
  • Exhibits74: Chart on Phototoxicity testing - Year-over-year growth 2024-2029 (%)
  • Exhibits75: Data Table on Phototoxicity testing - Year-over-year growth 2024-2029 (%)
  • Exhibits76: Chart on Dermal toxicity testing - Market size and forecast 2024-2029 ($ million)
  • Exhibits77: Data Table on Dermal toxicity testing - Market size and forecast 2024-2029 ($ million)
  • Exhibits78: Chart on Dermal toxicity testing - Year-over-year growth 2024-2029 (%)
  • Exhibits79: Data Table on Dermal toxicity testing - Year-over-year growth 2024-2029 (%)
  • Exhibits80: Market opportunity by Type ($ million)
  • Exhibits81: Data Table on Market opportunity by Type ($ million)
  • Exhibits82: Chart on Technology - Market share 2024-2029 (%)
  • Exhibits83: Data Table on Technology - Market share 2024-2029 (%)
  • Exhibits84: Chart on Comparison by Technology
  • Exhibits85: Data Table on Comparison by Technology
  • Exhibits86: Chart on Cell culture technology - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Cell culture technology - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Cell culture technology - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Cell culture technology - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Chart on High throughput screening - Market size and forecast 2024-2029 ($ million)
  • Exhibits91: Data Table on High throughput screening - Market size and forecast 2024-2029 ($ million)
  • Exhibits92: Chart on High throughput screening - Year-over-year growth 2024-2029 (%)
  • Exhibits93: Data Table on High throughput screening - Year-over-year growth 2024-2029 (%)
  • Exhibits94: Chart on OMICS technology - Market size and forecast 2024-2029 ($ million)
  • Exhibits95: Data Table on OMICS technology - Market size and forecast 2024-2029 ($ million)
  • Exhibits96: Chart on OMICS technology - Year-over-year growth 2024-2029 (%)
  • Exhibits97: Data Table on OMICS technology - Year-over-year growth 2024-2029 (%)
  • Exhibits98: Chart on Computational toxicology - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Data Table on Computational toxicology - Market size and forecast 2024-2029 ($ million)
  • Exhibits100: Chart on Computational toxicology - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Data Table on Computational toxicology - Year-over-year growth 2024-2029 (%)
  • Exhibits102: Market opportunity by Technology ($ million)
  • Exhibits103: Data Table on Market opportunity by Technology ($ million)
  • Exhibits104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits105: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits107: Chart on Geographic comparison
  • Exhibits108: Data Table on Geographic comparison
  • Exhibits109: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits158: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits159: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits160: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits161: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits162: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits163: Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits164: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits165: Market opportunity By Geographical Landscape ($ million)
  • Exhibits166: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits167: Impact of drivers and challenges in 2024 and 2029
  • Exhibits168: Overview on criticality of inputs and factors of differentiation
  • Exhibits169: Overview on factors of disruption
  • Exhibits170: Impact of key risks on business
  • Exhibits171: Companies covered
  • Exhibits172: Company ranking index
  • Exhibits173: Matrix on companies position and classification
  • Exhibits174: Abbott Laboratories - Overview
  • Exhibits175: Abbott Laboratories - Business segments
  • Exhibits176: Abbott Laboratories - Key news
  • Exhibits177: Abbott Laboratories - Key offerings
  • Exhibits178: Abbott Laboratories - Segment focus
  • Exhibits179: SWOT
  • Exhibits180: Agilent Technologies Inc. - Overview
  • Exhibits181: Agilent Technologies Inc. - Business segments
  • Exhibits182: Agilent Technologies Inc. - Key news
  • Exhibits183: Agilent Technologies Inc. - Key offerings
  • Exhibits184: Agilent Technologies Inc. - Segment focus
  • Exhibits185: SWOT
  • Exhibits186: Aragen Life Sciences Pvt. Ltd. - Overview
  • Exhibits187: Aragen Life Sciences Pvt. Ltd. - Product / Service
  • Exhibits188: Aragen Life Sciences Pvt. Ltd. - Key offerings
  • Exhibits189: SWOT
  • Exhibits190: Bio Rad Laboratories Inc. - Overview
  • Exhibits191: Bio Rad Laboratories Inc. - Business segments
  • Exhibits192: Bio Rad Laboratories Inc. - Key news
  • Exhibits193: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits194: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits195: SWOT
  • Exhibits196: Catalent Inc. - Overview
  • Exhibits197: Catalent Inc. - Business segments
  • Exhibits198: Catalent Inc. - Key offerings
  • Exhibits199: Catalent Inc. - Segment focus
  • Exhibits200: SWOT
  • Exhibits201: Charles River Laboratories International Inc. - Overview
  • Exhibits202: Charles River Laboratories International Inc. - Business segments
  • Exhibits203: Charles River Laboratories International Inc. - Key offerings
  • Exhibits204: Charles River Laboratories International Inc. - Segment focus
  • Exhibits205: SWOT
  • Exhibits206: Eurofins Scientific SE - Overview
  • Exhibits207: Eurofins Scientific SE - Business segments
  • Exhibits208: Eurofins Scientific SE - Key offerings
  • Exhibits209: Eurofins Scientific SE - Segment focus
  • Exhibits210: SWOT
  • Exhibits211: Evotec SE - Overview
  • Exhibits212: Evotec SE - Business segments
  • Exhibits213: Evotec SE - Key news
  • Exhibits214: Evotec SE - Key offerings
  • Exhibits215: Evotec SE - Segment focus
  • Exhibits216: SWOT
  • Exhibits217: Gentronix Ltd. - Overview
  • Exhibits218: Gentronix Ltd. - Product / Service
  • Exhibits219: Gentronix Ltd. - Key offerings
  • Exhibits220: SWOT
  • Exhibits221: Laboratory Corp. of America Holdings - Overview
  • Exhibits222: Laboratory Corp. of America Holdings - Business segments
  • Exhibits223: Laboratory Corp. of America Holdings - Key news
  • Exhibits224: Laboratory Corp. of America Holdings - Key offerings
  • Exhibits225: Laboratory Corp. of America Holdings - Segment focus
  • Exhibits226: SWOT
  • Exhibits227: Merck KGaA - Overview
  • Exhibits228: Merck KGaA - Business segments
  • Exhibits229: Merck KGaA - Key news
  • Exhibits230: Merck KGaA - Key offerings
  • Exhibits231: Merck KGaA - Segment focus
  • Exhibits232: SWOT
  • Exhibits233: Promega Corp. - Overview
  • Exhibits234: Promega Corp. - Product / Service
  • Exhibits235: Promega Corp. - Key offerings
  • Exhibits236: SWOT
  • Exhibits237: SGS SA - Overview
  • Exhibits238: SGS SA - Business segments
  • Exhibits239: SGS SA - Key offerings
  • Exhibits240: SGS SA - Segment focus
  • Exhibits241: SWOT
  • Exhibits242: Thermo Fisher Scientific Inc. - Overview
  • Exhibits243: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits244: Thermo Fisher Scientific Inc. - Key news
  • Exhibits245: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits246: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits247: SWOT
  • Exhibits248: XENOMETRIX AG - Overview
  • Exhibits249: XENOMETRIX AG - Product / Service
  • Exhibits250: XENOMETRIX AG - Key offerings
  • Exhibits251: SWOT
  • Exhibits252: Inclusions checklist
  • Exhibits253: Exclusions checklist
  • Exhibits254: Currency conversion rates for US$
  • Exhibits255: Research methodology
  • Exhibits256: Information sources
  • Exhibits257: Data validation
  • Exhibits258: Validation techniques employed for market sizing
  • Exhibits259: Data synthesis
  • Exhibits260: 360 degree market analysis
  • Exhibits261: List of abbreviations
目次
Product Code: IRTNTR72735

The in-vitro toxicity testing market is forecasted to grow by USD 8,192.4 mn during 2024-2029, accelerating at a CAGR of 11.7% during the forecast period. The report on the in-vitro toxicity testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing use of in-vitro toxicity testing by companies to reduce drug failures, presence of toxic substances, and growth in government initiatives related toxicology testing.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 202510.7%
CAGR11.7%
Incremental Value$8,192.4 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's in-vitro toxicity testing market is segmented as below:

By End-user

    • Pharmaceutical companies
    • Academic and research institutions
    • Others

By Type

    • Cytotoxicity testing
    • Genotoxicity testing
    • Organ-specific toxicity testing
    • Phototoxicity testing
    • Dermal toxicity testing

By Technology

    • Cell culture technology
    • High throughput screening
    • OMICS technology
    • Computational toxicology

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the advances in toxicology as one of the prime reasons driving the in-vitro toxicity testing market growth during the next few years. Also, surge in demand for cosmetics and increasing investments in drug discovery will lead to sizable demand in the market.

The report on the in-vitro toxicity testing market covers the following areas:

    • In-Vitro Toxicity Testing Market sizing
    • In-Vitro Toxicity Testing Market forecast
    • In-Vitro Toxicity Testing Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro toxicity testing market vendors that include Abbott Laboratories, Agilent Technologies Inc., Aragen Life Sciences Pvt. Ltd., Bio Rad Laboratories Inc., BioIVT LLC, Catalent Inc., Charles River Laboratories International Inc., Creative Bioarray, Creative Biolabs, Eurofins Scientific SE, Evotec SE, Gentronix Ltd., InSphero AG, Laboratory Corp. of America Holdings, MB Research Labs, Merck KGaA, Promega Corp., SGS SA, Thermo Fisher Scientific Inc., and XENOMETRIX AG. Also, the in-vitro toxicity testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Technology
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global In-Vitro Toxicity Testing Market 2019 - 2023
    • Historic Market Size - Data Table on Global In-Vitro Toxicity Testing Market 2019 - 2023 ($ million)
  • 5.2 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.3 Type segment analysis 2019 - 2023
    • Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • 5.4 Technology segment analysis 2019 - 2023
    • Historic Market Size - Technology Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 The AI impact on Global In-Vitro Toxicity Testing Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by End-user

  • 8.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 8.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 8.3 Pharmaceutical - Market size and forecast 2024-2029
    • Chart on Pharmaceutical - Market size and forecast 2024-2029 ($ million)
    • Data Table on Pharmaceutical - Market size and forecast 2024-2029 ($ million)
    • Chart on Pharmaceutical - Year-over-year growth 2024-2029 (%)
    • Data Table on Pharmaceutical - Year-over-year growth 2024-2029 (%)
  • 8.4 Academic and research institutions - Market size and forecast 2024-2029
    • Chart on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
    • Data Table on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
    • Chart on Academic and research institutions - Year-over-year growth 2024-2029 (%)
    • Data Table on Academic and research institutions - Year-over-year growth 2024-2029 (%)
  • 8.5 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 8.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

9 Market Segmentation by Type

  • 9.1 Market segments
    • Chart on Type - Market share 2024-2029 (%)
    • Data Table on Type - Market share 2024-2029 (%)
  • 9.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 9.3 Cytotoxicity testing - Market size and forecast 2024-2029
    • Chart on Cytotoxicity testing - Market size and forecast 2024-2029 ($ million)
    • Data Table on Cytotoxicity testing - Market size and forecast 2024-2029 ($ million)
    • Chart on Cytotoxicity testing - Year-over-year growth 2024-2029 (%)
    • Data Table on Cytotoxicity testing - Year-over-year growth 2024-2029 (%)
  • 9.4 Genotoxicity testing - Market size and forecast 2024-2029
    • Chart on Genotoxicity testing - Market size and forecast 2024-2029 ($ million)
    • Data Table on Genotoxicity testing - Market size and forecast 2024-2029 ($ million)
    • Chart on Genotoxicity testing - Year-over-year growth 2024-2029 (%)
    • Data Table on Genotoxicity testing - Year-over-year growth 2024-2029 (%)
  • 9.5 Organ-specific toxicity testing - Market size and forecast 2024-2029
    • Chart on Organ-specific toxicity testing - Market size and forecast 2024-2029 ($ million)
    • Data Table on Organ-specific toxicity testing - Market size and forecast 2024-2029 ($ million)
    • Chart on Organ-specific toxicity testing - Year-over-year growth 2024-2029 (%)
    • Data Table on Organ-specific toxicity testing - Year-over-year growth 2024-2029 (%)
  • 9.6 Phototoxicity testing - Market size and forecast 2024-2029
    • Chart on Phototoxicity testing - Market size and forecast 2024-2029 ($ million)
    • Data Table on Phototoxicity testing - Market size and forecast 2024-2029 ($ million)
    • Chart on Phototoxicity testing - Year-over-year growth 2024-2029 (%)
    • Data Table on Phototoxicity testing - Year-over-year growth 2024-2029 (%)
  • 9.7 Dermal toxicity testing - Market size and forecast 2024-2029
    • Chart on Dermal toxicity testing - Market size and forecast 2024-2029 ($ million)
    • Data Table on Dermal toxicity testing - Market size and forecast 2024-2029 ($ million)
    • Chart on Dermal toxicity testing - Year-over-year growth 2024-2029 (%)
    • Data Table on Dermal toxicity testing - Year-over-year growth 2024-2029 (%)
  • 9.8 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

10 Market Segmentation by Technology

  • 10.1 Market segments
    • Chart on Technology - Market share 2024-2029 (%)
    • Data Table on Technology - Market share 2024-2029 (%)
  • 10.2 Comparison by Technology
    • Chart on Comparison by Technology
    • Data Table on Comparison by Technology
  • 10.3 Cell culture technology - Market size and forecast 2024-2029
    • Chart on Cell culture technology - Market size and forecast 2024-2029 ($ million)
    • Data Table on Cell culture technology - Market size and forecast 2024-2029 ($ million)
    • Chart on Cell culture technology - Year-over-year growth 2024-2029 (%)
    • Data Table on Cell culture technology - Year-over-year growth 2024-2029 (%)
  • 10.4 High throughput screening - Market size and forecast 2024-2029
    • Chart on High throughput screening - Market size and forecast 2024-2029 ($ million)
    • Data Table on High throughput screening - Market size and forecast 2024-2029 ($ million)
    • Chart on High throughput screening - Year-over-year growth 2024-2029 (%)
    • Data Table on High throughput screening - Year-over-year growth 2024-2029 (%)
  • 10.5 OMICS technology - Market size and forecast 2024-2029
    • Chart on OMICS technology - Market size and forecast 2024-2029 ($ million)
    • Data Table on OMICS technology - Market size and forecast 2024-2029 ($ million)
    • Chart on OMICS technology - Year-over-year growth 2024-2029 (%)
    • Data Table on OMICS technology - Year-over-year growth 2024-2029 (%)
  • 10.6 Computational toxicology - Market size and forecast 2024-2029
    • Chart on Computational toxicology - Market size and forecast 2024-2029 ($ million)
    • Data Table on Computational toxicology - Market size and forecast 2024-2029 ($ million)
    • Chart on Computational toxicology - Year-over-year growth 2024-2029 (%)
    • Data Table on Computational toxicology - Year-over-year growth 2024-2029 (%)
  • 10.7 Market opportunity by Technology
    • Market opportunity by Technology ($ million)
    • Data Table on Market opportunity by Technology ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.9 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.10 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.11 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.12 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.13 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.14 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 12.15 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.16 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
    • SWOT
  • 15.5 Agilent Technologies Inc.
    • Agilent Technologies Inc. - Overview
    • Agilent Technologies Inc. - Business segments
    • Agilent Technologies Inc. - Key news
    • Agilent Technologies Inc. - Key offerings
    • Agilent Technologies Inc. - Segment focus
    • SWOT
  • 15.6 Aragen Life Sciences Pvt. Ltd.
    • Aragen Life Sciences Pvt. Ltd. - Overview
    • Aragen Life Sciences Pvt. Ltd. - Product / Service
    • Aragen Life Sciences Pvt. Ltd. - Key offerings
    • SWOT
  • 15.7 Bio Rad Laboratories Inc.
    • Bio Rad Laboratories Inc. - Overview
    • Bio Rad Laboratories Inc. - Business segments
    • Bio Rad Laboratories Inc. - Key news
    • Bio Rad Laboratories Inc. - Key offerings
    • Bio Rad Laboratories Inc. - Segment focus
    • SWOT
  • 15.8 Catalent Inc.
    • Catalent Inc. - Overview
    • Catalent Inc. - Business segments
    • Catalent Inc. - Key offerings
    • Catalent Inc. - Segment focus
    • SWOT
  • 15.9 Charles River Laboratories International Inc.
    • Charles River Laboratories International Inc. - Overview
    • Charles River Laboratories International Inc. - Business segments
    • Charles River Laboratories International Inc. - Key offerings
    • Charles River Laboratories International Inc. - Segment focus
    • SWOT
  • 15.10 Eurofins Scientific SE
    • Eurofins Scientific SE - Overview
    • Eurofins Scientific SE - Business segments
    • Eurofins Scientific SE - Key offerings
    • Eurofins Scientific SE - Segment focus
    • SWOT
  • 15.11 Evotec SE
    • Evotec SE - Overview
    • Evotec SE - Business segments
    • Evotec SE - Key news
    • Evotec SE - Key offerings
    • Evotec SE - Segment focus
    • SWOT
  • 15.12 Gentronix Ltd.
    • Gentronix Ltd. - Overview
    • Gentronix Ltd. - Product / Service
    • Gentronix Ltd. - Key offerings
    • SWOT
  • 15.13 Laboratory Corp. of America Holdings
    • Laboratory Corp. of America Holdings - Overview
    • Laboratory Corp. of America Holdings - Business segments
    • Laboratory Corp. of America Holdings - Key news
    • Laboratory Corp. of America Holdings - Key offerings
    • Laboratory Corp. of America Holdings - Segment focus
    • SWOT
  • 15.14 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
    • SWOT
  • 15.15 Promega Corp.
    • Promega Corp. - Overview
    • Promega Corp. - Product / Service
    • Promega Corp. - Key offerings
    • SWOT
  • 15.16 SGS SA
    • SGS SA - Overview
    • SGS SA - Business segments
    • SGS SA - Key offerings
    • SGS SA - Segment focus
    • SWOT
  • 15.17 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus
    • SWOT
  • 15.18 XENOMETRIX AG
    • XENOMETRIX AG - Overview
    • XENOMETRIX AG - Product / Service
    • XENOMETRIX AG - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations